GERALD PLOVSKY: Open Payments
NPI 1982641858 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$12,448 in 115 payments from 19 companies in 2025. Trend: 2023 $3,939 · 2024 $18,516 · 2025 $12,448
Speaker / faculty: $9,653Food & beverage: $2,795
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 17 | $9,940 |
| Alkermes, Inc. | 21 | $402 |
| Neurocrine BioSciences, Inc. | 13 | $359 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $345 |
| E.R. Squibb & Sons, L.L.C. | 9 | $276 |
| Axsome Therapeutics, Inc. | 6 | $216 |
| ABBVIE INC. | 15 | $197 |
| Janssen Pharmaceuticals, Inc | 4 | $170 |
| Vanda Pharmaceuticals Inc. | 3 | $158 |
| Braeburn Inc. | 1 | $125 |
Products named: REXULTI, INGREZZA, CAPLYTA, COBENFY, VRAYLAR, LYBALVI, SPRAVATO, Auvelity.
Industry payments across NC — which companies pay providers there.
